Device Trial Radar · NCT03621202
Safety and Accuracy of the Saranas EBBMS for the Detection of Endovascular Procedure Related Bleeding Events
Last checked: Nov 20, 2026Latest source record: Dec 28, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
66
Actual
Start
Aug 13, 2018
Primary completion
Jun 30, 2019
Study completion Jun 30, 2019
Sponsor
- Lead sponsor
- Saranas, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Proxima CRO; Medical Metrics Diagnostics, Inc
- First posted
- Aug 8, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety and accuracy of the Saranas EBBMS for the detection of access site related internal bleeding events during large-bore endovascular procedures.
Conditions
- Endovascular Procedures
Interventions
Saranas Early Bird Bleed Monitoring System (EBBMS)Device
Participants will undergo their planned endovascular procedure with monitoring for internal bleeding using the Saranas EBBMS.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cohen's Kappa Coefficient (κ)Time frame: Up to 8 hours post procedure
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
North Florida Regional Medical Center
Gainesville, Florida
Morristown Medical Center
Morristown, New Jersey
Columbia University Medical Center
New York, New York
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.